Coronary stent EverPro

cobalt-chromiumpolymerdrug eluting

AN IDEAL STENT MATERIAL The Cobalt Chromium L605 métal alloy is a proven stent platform in several dinical trials for its strength and compatibility. THE SCHIFSORB POLYMER TECHNOLOGY It takes something extraordinary to stand apart and overcome any hurdle. SLTL incorporated the advanced Schifsorb Polymer Technology. This revolutionary technology by SLTL pairs the power of biodegradable PLLA and PLGA polymers with an Integrated Everolimus drug. The Schifsorb polymer technology of the EverPro delivers a dynamic performance along with great drug release efficiency up to 48 days. The thrombus-resistant polymer degrades with minimal tissue inflammation, which truly underplays risk of stent thrombosis. THE ELECTRO-POLISHING The status-quo electro-polishing process provides ultra smooth stent surface, reduces risk of edge dissection and very late stent thrombosis. THE DRUG COATING The conformal coating of Everolimus at a dose of 1.1 pg/mm2 provides optimum anti-proliferation and endothelial regeneration, which in-turn assist to reduce restenosis. THE STENT DESIGN With U.S. patented alternate "C" and "S" links are what make EverPro stand apart, it blends sophistication with a design philosophy that is bold and unparalleled. Finely engineered elements of an expansive Cobalt Chromium L605 platform, enhances stent flexibility. THE LASER CUTTING A bold stance and elegant curves with highly accurate fiber laser machine provides dimension accuracy of 2 p, which makes EverPro stand apart.